VEROVACCiNES

Halle, Germany Founded: 2017 • Age: 9 yrs
Developer of animal vaccines to treat infectious diseases
Request Access

About VEROVACCiNES

VEROVACCiNES is a company based in Halle (Germany) founded in 2017.. VEROVACCiNES offers products and services including Subunit Vaccine Platform and Recombinant Yeast Strains. VEROVACCiNES operates in a competitive market with competitors including Merck Animal Health, TARGAN, Aptimmune Biologics, Indian Immunologicals and ViroVet, among others.

  • Headquarter Halle, Germany
  • Sectors
    Healthcare
    Agriculture
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Eqmania Ug
Operational Areas
Healthcare → Veterinary & Animal Health
Agriculture → Livestock & Animal Nutrition
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    GO-Bio

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of VEROVACCiNES

VEROVACCiNES offers a comprehensive portfolio of products and services, including Subunit Vaccine Platform and Recombinant Yeast Strains. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Platform for rapid creation and optimization of animal vaccines using yeast strains.

Strains that express antigens for vaccine development in animal health.

Funding Insights of VEROVACCiNES

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round
  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2019 Amount Grant - VEROVACCiNES Valuation

investors

Dec, 2019 Amount Seed - VEROVACCiNES Valuation HTGF
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in VEROVACCiNES

VEROVACCiNES has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include GO-Bio and High-Tech Gründerfonds. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage investments are made in high-tech startups by HTGF.
Founded Year Domain Location
Funding is provided for biotechnology research and innovation projects.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by VEROVACCiNES

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - VEROVACCiNES

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Verovaccines Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of VEROVACCiNES

VEROVACCiNES operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck Animal Health, TARGAN, Aptimmune Biologics, Indian Immunologicals and ViroVet, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Vaccine technology is developed and supplied for livestock animals.
domain founded_year HQ Location
Automated targeted vaccine systems for livestock and aquaculture are developed.
domain founded_year HQ Location
Swine vaccines are developed using advanced mucosal technology.
domain founded_year HQ Location
Vaccines for animal and human health are manufactured.
domain founded_year HQ Location
Manufacturer and supplier of antiviral drugs for livestock
domain founded_year HQ Location
Offers patented immunostimulating vaccines for livestock.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Verovaccines

Frequently Asked Questions about VEROVACCiNES

When was VEROVACCiNES founded?

VEROVACCiNES was founded in 2017 and raised its 1st funding round 2 years after it was founded.

Where is VEROVACCiNES located?

VEROVACCiNES is headquartered in Halle, Germany. It is registered at Halle, Sachsen-anhalt, Germany.

What does VEROVACCiNES do?

VEROVACCiNES was founded in 2017 in Halle, Germany, within the biotechnology sector focused on animal health. Novel vaccines are developed for treating infectious diseases in animals, utilizing recombinant strains of the yeast Kluyveromyces lactis. Antigens are expressed by these strains to target various pathogens. Operations center on research and production of these specialized immunizations, with a presence maintained through the domain verovaccines.com.

Who are the top competitors of VEROVACCiNES?

VEROVACCiNES's top competitors include TARGAN, Merck Animal Health and Indian Immunologicals.

What products or services does VEROVACCiNES offer?

VEROVACCiNES offers Subunit Vaccine Platform and Recombinant Yeast Strains.

Who are VEROVACCiNES's investors?

VEROVACCiNES has 2 investors. Key investors include GO-Bio, and High-Tech Gründerfonds.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available